Regeneron Pharmaceuticals Inc. (REGN) reported first quarter net income of $0.90 per share Friday morning, up from $0.11 per share in the prior year. The consensus estimate was for EPS of $0.95. Revenues increased to $440 million, compared to $232 million last year. The consensus estimate was for revenues of $424.26 million.
Regeneron Pharmaceuticals gapped up sharply Friday and climbed in early trade, before settling into a range. Shares finished with a gain of 17.53 at $266.16 on above average volume. The stock rose to a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.